Medico-economic Evaluation of Management Strategies for Severe Epistaxis
Condition(s):EpistaxisLast Updated:August 29, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):EpistaxisLast Updated:August 29, 2023Recruiting
Condition(s):Epistaxis NosebleedLast Updated:November 22, 2023Recruiting
Condition(s):Hereditary Hemorrhagic Telangiectasia; EpistaxisLast Updated:September 8, 2022Not yet recruiting
Condition(s):Hereditary Hemorrhagic Telangiectasia; Nosebleeds; EpistaxisLast Updated:March 5, 2024Recruiting
Condition(s):Epistaxis, Anterior Ethmoid ArteryLast Updated:December 19, 2023Recruiting
Condition(s):Hereditary Hemorrhagic Telangiectasia; Epistaxis; Anemia; Nosebleed; HHTLast Updated:February 28, 2024Recruiting
Condition(s):Telangiectasia, Hereditary HemorrhagicLast Updated:July 26, 2022Recruiting
Condition(s):Bleeding NoseLast Updated:April 13, 2023Recruiting
Condition(s):Shellfish Hypersensitivity; EpistaxisLast Updated:September 11, 2023Not yet recruiting
Condition(s):Chronic Sinusitis; Tumor of Nasal Sinus; Posterior Epistaxis; Skull Base NeoplasmsLast Updated:November 14, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.